Cell News and Research

RSS
New antibody with SGN-35 drug produces remission in Hodgkin lymphoma

New antibody with SGN-35 drug produces remission in Hodgkin lymphoma

Study links positive well-being to higher telomerase activity

Study links positive well-being to higher telomerase activity

Aduro receives $442,000 grant under QTDP program to support Listeria-based immunotherapy platform

Aduro receives $442,000 grant under QTDP program to support Listeria-based immunotherapy platform

BioCurex files patent for synthetic peptide in RECAF test

BioCurex files patent for synthetic peptide in RECAF test

Aeolus receives $489,000 grant under QTDP program for two lead compounds

Aeolus receives $489,000 grant under QTDP program for two lead compounds

SurModics and Edge Therapeutics enter licensing agreement for drug delivery technology

SurModics and Edge Therapeutics enter licensing agreement for drug delivery technology

BioSpecifics receives $426,000 grant under QTDP Program

BioSpecifics receives $426,000 grant under QTDP Program

Electrolytic Ozone completes Series A funding

Electrolytic Ozone completes Series A funding

Regulus receives $488,989 grant under QTDP program

Regulus receives $488,989 grant under QTDP program

New simple blood test may help diagnose Niemann-Pick type C disease

New simple blood test may help diagnose Niemann-Pick type C disease

Alnylam third quarter revenue increases from $24.2 million to $27.7 million

Alnylam third quarter revenue increases from $24.2 million to $27.7 million

Bortezomib reduces inflammation and promotes bone healing in arthritis models

Bortezomib reduces inflammation and promotes bone healing in arthritis models

ADVENTRX submits NDA for Exelbine to FDA

ADVENTRX submits NDA for Exelbine to FDA

Top 10 Medical Innovations for 2011

Top 10 Medical Innovations for 2011

Fibrocell, Meifu to develop and market autologous fibroblast therapies in Asia

Fibrocell, Meifu to develop and market autologous fibroblast therapies in Asia

Safeguard Scientifics third quarter aggregate revenue of partner companies increases 73% to $109.6 million

Safeguard Scientifics third quarter aggregate revenue of partner companies increases 73% to $109.6 million

Lifestyle changes and natural supplements can control blood sugar levels

Lifestyle changes and natural supplements can control blood sugar levels

Risk of dying 24% greater if patient first stops at non-trauma center

Risk of dying 24% greater if patient first stops at non-trauma center

New technique could help scientists to predict how living prostate tissues respond to therapy

New technique could help scientists to predict how living prostate tissues respond to therapy

New global map shows distribution of sickle cell gene

New global map shows distribution of sickle cell gene

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.